Tiffany Hung currently serves as Medical Director at GRAIL, Inc., leading clinical strategy for technology development in cancer care, focusing on diagnostic solutions for therapy co-development. Previously, Tiffany held the position of Senior Companion Diagnostics Lead at Genentech, where responsibilities included executing clinical diagnostic strategies for precision oncology and leading teams in diagnostic strategy development. Earlier roles at Genentech and Celgene involved significant contributions to biomarker and diagnostic strategy development, with expertise in complex biomarkers and drug registration in the APAC region. Tiffany began a career in research as a Fellow at Genentech and has also consulted for CardioVascular Resource Group. Educational credentials include a B.S. with Honors in Biology and a Ph.D. in Cancer Biology from Stanford University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices